Cna Financial Corp Deciphera Pharmaceuticals, Inc. Transaction History

Cna Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$32.73 - $47.95 $383,595 - $561,974	-11,720 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $108,649 - $152,603	2,690 Added 29.79%	11,720 $526,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $1,035 - $1,323	20 Added 0.22%	9,030 $515,000
Q3 2020 Nov 12, 2020	BUY	$43.8 - $58.16 $55,626 - $73,863	1,270 Added 16.41%	9,010 $462,000
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $286,767 - $503,332	7,740 New	7,740 $462,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.